RecruitingInterventionalNot ApplicableUpdated Jan 13, 2025
Exploration of Management Model and Intervention Research on Fear of Cancer Recurrence | NCT05922423 | Trialant
Unknown statusInterventionalNot ApplicableUpdated Mar 22, 2024
Exploration of Management Model and Intervention Research on Fear of Cancer Recurrence
Exploration of Management Model and Intervention Research on Fear of Cancer Recurrence
ClinicalTrials.gov ID
NCT05922423
Lead Sponsor
Nanfang Hospital, Southern Medical UniversityOTHER
Overall Status
Unknown status
Study Type
Interventional
Phase
Not Applicable
Enrollment
130Estimated
Last Update Posted
Mar 22, 2024Actual
Start Date
Mar 2024Estimated
Primary Completion Date
Dec 2024Estimated
Completion Date
Dec 2024Estimated
Official Title
Exploration of Management Model and Intervention Research on Fear of Cancer Recurrence
Brief Summary
Through cross-sectional investigation and research, construct an fear of cancer recurrence warning model to identify and screen high fear of cancer recurrencecancer populations, in order to identify predictive factors for high fear of cancer recurrence, study how cancer patients develop susceptibility to fear of cancer recurrence during the diagnosis and treatment process, including which participating factors, explore the development trajectory of fear of cancer recurrence, and effectively prevent the occurrence of high-level fear of cancer recurrence.
Through randomized controlled trials, conduct a study on mindfulness and stress reduction psychosocial intervention for high-level fear of cancer recurrence patients, verify the effectiveness of psychosocial intervention measures targeting domestic cancer populations, and improve standardized intervention methods, intervention time, and treatment content.
Cancer Patients
MBSR
health education
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
Adults aged ≥ 18 years old
Consistent with pathological diagnosis of cancer
Able to understand and comply with research protocols
Written informed consent can be provided
Own and know how to use smart ·terminals (such as smartphones, tablets, computers, etc.)
Exclusion Criteria:
Patients with mental illness and consciousness disorders;
Patients with cancer metastasis or recurrence
End of life treatment for patients.
Primary Purpose
Supportive Care
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
Single
Luo xian, DoctorContact
2443180803@qq.com15521073773
No locations
There are no locations for this study.
Lead Sponsor
Nanfang Hospital, Southern Medical UniversityOTHER